Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort

NAUnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

April 30, 2025

Conditions
COPD Exacerbation
Interventions
OTHER

Experimental

Patients will be every two weeks monitored by the researchers' team, taking into consideration lung function, symptoms, physical activity, pulse oximetry, body temperature, need for relief medication and Sputum characteristics. Over the 18 months, they will be the target of health education interventions, 2 individual and 2 in group.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Minho

OTHER